The Barbara Ann Karmanos Cancer Institute has expanded access of three groundbreaking cancer therapies to Karmanos Cancer Network locations in Michigan. As part of Karmanos' theranostics program, ...

A new drug, Elraglusib, has doubled the survival rate for patients with pancreatic cancer, giving hope and extra time to ...

Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.

Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Targeted therapy is reaching more patients than ever, but access still depends on factors like cost, insurance coverage, geography, and cancer type. These treatments offer precision and strong ...

Data highlight RM-055's ability to overcome resistance and provide deep, durable antitumor activity across preclinical models ...

An expert discusses how long-term safety considerations are evaluated through clinical trial data and postmarketing surveillance, emphasizing the importance of reporting unexpected adverse events to ...

An investigational targeted therapy doubled survival compared with standard chemotherapy for pretreated individuals with ...

Cancer drugs are designed to shut tumors down. But sometimes, in the very act of attacking a tumor, treatment can also help a ...

By Bhanvi Satija LONDON, April 12 (Reuters) - British drugmaker GSK's experimental targeted cancer drug Mo-rez has ...

The Barbara Ann Karmanos Cancer Institute in Detroit has expanded access to three radiopharmaceutical cancer therapies to Karmanos Cancer Network locations in Michigan.